XENE
Xenon Pharmaceuticals Inc

2,731
Mkt Cap
$4.59B
Volume
1.5M
52W High
$63.95
52W Low
$26.74
PE Ratio
-12.66
XENE Fundamentals
Price
$55.07
Prev Close
$55.20
Open
$54.93
50D MA
$44.28
Beta
0.84
Avg. Volume
812,656.13
EPS (Annual)
-$4.36
P/B
7.59
Rev/Employee
$20,270.27
$3,011.21
Loading...
Loading...
News
all
press releases
Jain Global LLC Takes Position in Xenon Pharmaceuticals Inc. $XENE
Jain Global LLC bought a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 252,379...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Holocene Advisors LP Acquires 167,078 Shares of Xenon Pharmaceuticals Inc. $XENE
Holocene Advisors LP boosted its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 9.2% in the third quarter, according to the company in its most recent 13F filing with...
MarketBeat·1d ago
News Placeholder
Xenon Pharmaceuticals Inc. $XENE Shares Sold by Granahan Investment Management LLC
Granahan Investment Management LLC decreased its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 63.6% during the third quarter, according to the company in its most recent...
MarketBeat·1d ago
News Placeholder
Cinctive Capital Management LP Takes Position in Xenon Pharmaceuticals Inc. $XENE
Cinctive Capital Management LP purchased a new stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) in the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·2d ago
News Placeholder
Xenon Pharmaceuticals (NASDAQ:XENE) Price Target Cut to $63.00 by Analysts at Wedbush
Wedbush decreased their price objective on Xenon Pharmaceuticals from $64.00 to $63.00 and set an "outperform" rating for the company in a report on Monday...
MarketBeat·2d ago
News Placeholder
HighVista Strategies LLC Increases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE
HighVista Strategies LLC boosted its stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 80.2% in the third quarter, according to its most recent filing with the Securities and...
MarketBeat·2d ago
News Placeholder
Commodore Capital LP Has $108.41 Million Position in Xenon Pharmaceuticals Inc. $XENE
Commodore Capital LP trimmed its holdings in shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Free Report) by 10.7% during the 3rd quarter, according to its most recent disclosure with the...
MarketBeat·3d ago
News Placeholder
Christopher John Kenney Sells 1,410 Shares of Xenon Pharmaceuticals (NASDAQ:XENE) Stock
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) insider Christopher John Kenney sold 1,410 shares of the company's stock in a transaction dated Friday, March 13th. The stock was sold at an...
MarketBeat·5d ago
News Placeholder
Xenon Pharmaceuticals (NASDAQ:XENE) Insider Andrea Difabio Sells 1,342 Shares
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) insider Andrea Difabio sold 1,342 shares of the stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average...
MarketBeat·5d ago
News Placeholder
Xenon Pharmaceuticals (NASDAQ:XENE) CEO Sells $403,620.84 in Stock
Xenon Pharmaceuticals Inc. (NASDAQ:XENE - Get Free Report) CEO Ian Mortimer sold 7,308 shares of the company's stock in a transaction on Friday, March 13th. The stock was sold at an average price of...
MarketBeat·5d ago
<
1
2
...
>

Latest XENE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.